These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9925977)
21. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines. Mehta SR; J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860 [TBL] [Abstract][Full Text] [Related]
22. [Coronary insufficiency and heparin]. Nicolau JC; Ramires JA Arq Bras Cardiol; 1991 Aug; 57(2):141-50. PubMed ID: 1823773 [No Abstract] [Full Text] [Related]
23. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. Blazing MA; de Lemos JA; White HD; Fox KA; Verheugt FW; Ardissino D; DiBattiste PM; Palmisano J; Bilheimer DW; Snapinn SM; Ramsey KE; Gardner LH; Hasselblad V; Pfeffer MA; Lewis EF; Braunwald E; Califf RM; JAMA; 2004 Jul; 292(1):55-64. PubMed ID: 15238591 [TBL] [Abstract][Full Text] [Related]
24. [Comparative efficacy of tiklid and aspirin in patients with unstable angina]. Rebrov AP; Voskoboĭ IV Ter Arkh; 2001; 73(12):25-9. PubMed ID: 11858103 [TBL] [Abstract][Full Text] [Related]
25. Management of acute coronary syndromes. Schulman SP; Fessler HE Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971 [No Abstract] [Full Text] [Related]
26. Antiplatelet and antithrombotic therapy in unstable angina. Théroux P Am J Cardiol; 1991 Sep; 68(7):92B-98B. PubMed ID: 1892073 [TBL] [Abstract][Full Text] [Related]
27. Treatment options in unstable angina: a clinical update. Fox KA; Antman EM Eur Heart J; 1998 Sep; 19 Suppl K():K8-10. PubMed ID: 9790283 [TBL] [Abstract][Full Text] [Related]
28. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. Collins R; Peto R; Baigent C; Sleight P N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095 [No Abstract] [Full Text] [Related]
29. Aspirin or heparin immediately after a stroke? Bousser MG Lancet; 1997 May; 349(9065):1564-5. PubMed ID: 9174553 [No Abstract] [Full Text] [Related]
30. Low molecular weight heparins in acute coronary syndrome. Creekmore F S D J Med; 2000 Jan; 53(1):21-3. PubMed ID: 10652862 [No Abstract] [Full Text] [Related]
32. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina. McDonagh MS; Bachmann LM; Golder S; Kleijnen J; ter Riet G Health Technol Assess; 2000; 4(30):1-95. PubMed ID: 11154975 [No Abstract] [Full Text] [Related]
33. [Current therapy for unstable angina pectoris]. Burkhard-Meier C; Deutsch HJ; Erdmann E Dtsch Med Wochenschr; 1999 Jun; 124(23):733-9. PubMed ID: 10396308 [No Abstract] [Full Text] [Related]
34. Management of acute coronary syndromes with emphasis on new information for the treatment of ST-segment elevation acute myocardial infarction. Lincoff AM J Invasive Cardiol; 2002 Feb; 14 Suppl A():1A-2A. PubMed ID: 11847401 [No Abstract] [Full Text] [Related]
35. Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina. Steinhubl SR; Moliterno DJ Heart Vessels; 1997; Suppl 12():148-55. PubMed ID: 9476567 [TBL] [Abstract][Full Text] [Related]
36. Economic assessment of tirofiban in the management of acute coronary syndromes in the hospital setting: an analysis based on the PRISM PLUS trial. Szucs TD; Meyer BJ; Kiowski W Eur Heart J; 1999 Sep; 20(17):1253-60. PubMed ID: 10454977 [TBL] [Abstract][Full Text] [Related]
37. Two new antiplatelet drugs for angioplasty and acute coronary syndromes. Med Lett Drugs Ther; 1998 Sep; 40(1035):89-90. PubMed ID: 9760948 [No Abstract] [Full Text] [Related]
38. Unstable angina and non-Q-wave myocardial infarction. Treatment beyond aspirin and heparin. Theroux P Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):799. PubMed ID: 12497824 [No Abstract] [Full Text] [Related]
39. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI. Ferguson JJ; Wilson JM; Diez J Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162 [TBL] [Abstract][Full Text] [Related]
40. Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients. Keularts IM; Béguin S; de Zwaan C; Hemker HC Thromb Haemost; 1998 Sep; 80(3):370-1. PubMed ID: 9759611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]